Connect with us

Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill

Published

on

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill


Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, Sept. 15, 2021.

Smith Collection | Gado | Getty Images

Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight loss pill through its digital pharmacy.

Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the U.S. on Monday, offering a starting dose for cash-paying patients at $149 per month. Patients with insurance coverage can get the pill for as low as $25 a month.

The daily pill enters the market with some of the lowest cash prices in the booming obesity and diabetes drug space, which costly weekly injections from Novo Nordisk and Eli Lilly have long dominated. Its availability on Amazon underscores Novo Nordisk’s strategy to expand beyond traditional channels and reach new patients.

Amazon said eligible customers with insurance can pay as little as $25 for a one-month supply of the drug. Its cash-pay option will start at $149 a month.

In the coming weeks, Amazon said it will also offer the Wegovy pill through its prescription vending kiosks, which are located in select One Medical clinics.

The e-commerce giant launched Amazon Pharmacy in 2020 as part of its deeper push into the multitrillion-dollar U.S. health-care industry. The service was born out of its acquisition of online pharmacy PillPack for roughly $750 million in 2018. It then bought primary-care clinic One Medical in 2022 for $3.9 billion.

Amazon has sought to attract users to its service by offering speedy delivery and price transparency. It offers same-day prescription delivery to nearly half of U.S. consumers, Amazon said.

The company hasn’t disclosed how many users Amazon Pharmacy has, but analysts have estimated it could generate about $2 billion in annual revenue.

In October, Weight Watchers said it would partner with Amazon Pharmacy to deliver weight loss medications for its members. Amazon Pharmacy has also collaborated with Eli Lilly to help deliver certain prescription medications, including its obesity drug Zepbound, purchased through the drugmaker’s direct-to-consumer website.

After its launch this week, the Novo Nordisk pill is also available at more than 70,000 U.S. pharmacies such as CVS and Costco, as well as select telehealth providers, including Ro, LifeMD, Weight Watchers, GoodRx and Novo Nordisk’s NovoCare Pharmacy.

Cash-paying patients will also be able to access the starting dose of the pill for $149 per month on President Donald Trump‘s direct-to-consumer website, TrumpRx, under a deal Novo Nordisk struck with his administration in November. The site also launches in January, though it’s unclear when.

Health experts say oral options could expand obesity treatment access in the U.S., likely reaching entirely new people who were afraid of needles or believed injections were too serious or aggressive for them to start.

Eli Lilly has a rival obesity pill that is slated to win Food and Drug Administration approval later this year.



Source link

Business

Day 3: Clean Max Enviro Energy IPO Vs Shree Ram Twistex IPO; Know GMP, Subscription And Reviews

Published

on

Day 3: Clean Max Enviro Energy IPO Vs Shree Ram Twistex IPO; Know GMP, Subscription And Reviews


Last Updated:

Clean Max Enviro Energy and Shree Ram Twistex IPOs are open for public subscription till 5 pm today; here’s which one looks better.

Clean Max Enviro Energy IPO Vs Shree Ram Twistex IPO.

Clean Max Enviro Energy IPO Vs Shree Ram Twistex IPO.

Two mainboard IPOs — Clean Max Enviro Energy Solutions and Shree Ram Twistex — have been closed today, February 25. The IPOs offer investors a choice between a renewable energy infrastructure play and a textile manufacturing bet. Here’s a comparison based on subscription data, grey market premium (GMP), valuations and broker views.

Subscription Status (Day 3)

On Day 3, Clean Max Enviro Energy IPO was subscribed 0.99 times. QIB demand stood at 2.99x, NII at 0.57x and retail at 0.07x, indicating subdued interest from investors.

Shree Ram Twistex IPO saw overall subscription of 43.66 times. Retail demand was at 76.63x, while QIB participation was 3.94x and NII stood at 220.30x.

Price Band And Issue Size

Clean Max Enviro Energy IPO is a Rs 3,100-crore issue comprising Rs 1,200 crore fresh issue and Rs 1,900 crore offer for sale. The price band is Rs 1,000-Rs 1,053 per share and minimum retail investment is Rs 14,742 for one lot of 14 shares.

Shree Ram Twistex IPO is a much smaller Rs 110.24-crore fresh issue priced at Rs 95-Rs 104 per share. Retail investors need Rs 14,976 to apply for one lot of 144 shares.

Grey Market Premium (GMP)

Clean Max Enviro’s GMP stood at (-)Rs 3, implying an estimated listing price of Rs 1,050, suggesting negative listing.

Shree Ram Twistex GMP was Rs 16.5, indicating an estimated listing price of Rs 120.5, or about 15.87% potential upside.

Both companies will be listed on BSE and NSE on March 2.

Business Positioning

Clean Max is India’s largest commercial and industrial (C&I) renewable energy service provider with roughly 8% market share. Analysts note the segment has a potential market size of about Rs 3 lakh crore as corporates — which consume nearly half of India’s electricity — increasingly shift toward green energy.

Shree Ram Twistex operates in the textile sector as a cotton yarn manufacturer serving B2B markets. Industry estimates suggest India’s textile sector could grow from about $174 billion to $350 billion by 2030, driven by exports, sustainability trends and policy support.

Analysts’ Views

SBI Securities highlighted Clean Max’s capital-efficient model and relatively low leverage, but noted the IPO is valued at EV/EBITDA of about 21.7x (FY25) and 16.3x (annualised 1HFY26).

Aditya Birla Capital said, “At the upper price-band, the issue is valued at 16x EV/Ebitda, which according to us, is expensive,” though it assigned a ‘Subscribe for long-term’ rating citing industry growth visibility.

For Shree Ram Twistex, Swastika Investmart said valuation at around 29-30x P/E already factors in most future growth and advised investors seeking listing gains to avoid the issue. Master Capital Services noted investors may consider it as a long-term opportunity given sector growth prospects.

Use Of Proceeds

Clean Max will use Rs 1,125 crore from fresh proceeds to repay debt, with the remainder for general corporate purposes.

Shree Ram Twistex will deploy proceeds for business expansion and operational requirements as it is entirely a fresh issue.

Which IPO Looks Better?

For listing gains, Shree Ram Twistex currently shows stronger grey market sentiment and investor traction. Clean Max, on the other hand, has stronger QIB participation but muted GMP, suggesting institutional conviction but limited short-term listing pop expectations.

For long-term investors, both issues are being viewed positively but with valuation caution. Clean Max offers exposure to the fast-growing renewable C&I power segment, while Shree Ram Twistex provides a play on India’s expanding textile exports and domestic demand.

Disclaimer:Disclaimer: The views and investment tips shared in this article are for general information purposes only. Readers are advised to consult a certified financial advisor before making any investment decisions.

Click here to add News18 as your preferred news source on Google.

Check Vijay Deverakonda and Rashmika Mandanna Marriage Latest News and Photos

Follow News18 on Google. Join the fun, play games on News18. Stay updated with all the latest business news, including market trends, stock updates, tax, IPO, banking finance, real estate, savings and investments. To Get in-depth analysis, expert opinions, and real-time updates. Also Download the News18 App to stay updated.

News business ipo Day 3: Clean Max Enviro Energy IPO Vs Shree Ram Twistex IPO; Know GMP, Subscription And Reviews
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Continue Reading

Business

HSBC to meet £1.1bn cost savings target early after cutting back senior roles

Published

on

HSBC to meet £1.1bn cost savings target early after cutting back senior roles



HSBC has revealed it stripped out 1.2 billion dollars (£890 million) worth of costs last year after cutting back its senior management team, as it hiked bonuses for staff by 10%.

The global banking giant has been embarking on a sprawling simplification programme that has involved big changes to its structure, in a bid to become more “agile”.

It previously set a target to make 1.5 billion dollars (£1.1 billion) in annual cost reductions by the end of 2026, under the leadership of chief executive Georges Elhedery.

But on Wednesday, the bank revealed that it is expecting to achieve this by the end of June – six months ahead of schedule.

It follows some 1.2 billion dollars (£890 million) worth of cost savings being found during 2025 alone.

Mr Elhedery, who stepped into the top job in 2024, said that a large amount of the savings had come from the “deduplication” of jobs within the group, particularly among more senior positions.

He said this resulted in a net 15% reduction of managing director positions, which has not had any impact on the group’s revenues.

Meanwhile, HSBC revealed that it handed out bonuses worth 3.9 billion dollars (£2.9 billion) to its eligible staff during the year – a 10% increase compared with 2024.

The bank said it ensured its “highest performers had the strongest variable pay outcomes compared to the prior year”.

Mr Elhedery took home a pay packet of £6.6 million in 2025, made up of his salary and benefits, plus an annual bonus and long-term incentive award of about £4.8 million.

HSBC’s pay committee said it intends to grant the chief executive the maximum long-term incentive award worth 600% of his salary, which amounts to £9 million, for 2026-28.

The value will be subject to the bank’s performance over the next three years, and delivered in instalments.

HSBC said it was striving to create a “high-performance culture” where staff are better rewarded for work that boosts the performance of the bank.

Nevertheless, it reported lower earnings for 2025, with its pre-tax profit down about 7% year-on-year to 29.9 billion dollars (£22.1 billion).

This took into account the impact of losses related to its stake in the Chinese Bank of Communications, and restructuring costs from its simplification programme.

Shares in HSBC were up by about 6% in early trading on Wednesday.



Source link

Continue Reading

Business

Energy bills to fall in April in price cap change and charges shake-up

Published

on

Energy bills to fall in April in price cap change and charges shake-up



Changes announced in the Budget mean all energy bills will see some kind of reduction, but it will vary.



Source link

Continue Reading

Trending